Ivac hopes to raise $100 million to repay debt
This article was originally published in Clinica
Executive Summary
Ivac, a Californian manufacturer of infusion systems, is tapping the US bond market for $100 million to repay debt. In late 1994, Ivac was purchased by a group of investors for $185 million from Eli Lilly which left the company with long-term debt of $130 million.